Social Vital Sign Program brings together hospitals, community organizations to address social isolation

A new cross-sector partnership is taking a bold step to address one of the most pressing challenges facing ol...

More Ontarians are being diagnosed with psychosis than those born in earlier decades

A new study suggests that people born more recently are being diagnosed with psychotic disorders (e.g., schiz...

Understanding where people with opioid use disorder die: why palliative care setting matters

A new study published in the Journal of Palliative Care examines how receipt of palliative care relates to th...

The Roots of Wisdom explores end-of-life decision-making

The Roots of Wisdom is on display in the atrium of Bruyère Health’s Saint-Vincent Hospital from Ja...

New Living Lab aims to reimagine an integrated health system

Michelle LA Nelson, PhD joins Bruyère Health Research Institute and Brain-Heart Interconnectome.

Bruyère Health Ranks as Number One Canadian Hospital in its Tier for Research Spending Growth for Second Cons...

Bruyère Health is proud to stand among the hospitals, universities, and colleges in the region, highligh...

Canadian health leaders launch digital initiative to prepare for new wave of Alzheimer's therapies

A coalition of Canada's top dementia experts will test the Foresight™ platform by Canadian-based Percei...

Bruyère Health patients and artist Christopher Griffin bring their inspiring Hallways of Hope collection to t...

The Art of a Good Death

National Art Exhibition Inspires Canadian Artists to Reimagine the End of Life

Health Canada decision on Alzheimer’s treatment opens new options for Canadians

Health Canada has now approved the use of lecanemab for treating early-stage Alzheimer’s disease.